Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.15 +0.40 (+2.75%)
As of: Oct 2, 2026 · 11:03 AM EDT

Ultragenyx Pharmaceutical (RARE) Shares Outstanding (Entity) (2013 - 2026)

Updated

Ultragenyx Pharmaceutical's Shares Outstanding (Entity) came in at 98.6 million for Q2 2026, up 2.3% from 96.35 million a year earlier and up 0.3% from the prior quarter.

Analysis

Ultragenyx Pharmaceutical (RARE) Shares Outstanding (Entity) (2013 - 2026) Analysis & Trends

For FY2025, Ultragenyx Pharmaceutical's Shares Outstanding (Entity) was 96.6 million, up 4.5% from FY2024.

  • Shares Outstanding (Entity) has increased in each of the last 13 years, with a five-year compound annual growth rate of 7.7% (FY2020 to FY2025).
  • Going back by year, Shares Outstanding (Entity) was 92.48 million in FY2024 (+12.4%), 82.32 million in FY2023 (+17.3%), 70.2 million in FY2022 (+1.2%) and 69.34 million in FY2021 (+3.8%).
  • The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2013.
  • Year-over-year, Shares Outstanding (Entity) has increased for 50 consecutive quarters, with growth averaging 9.2% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 1.2% (Q4 2022) to 28.9% (Q2 2024).
  • Business Quant data shows RARE's Shares Outstanding (Entity) at 98.3 million (Q1 2026), 96.6 million (Q4 2025) and 96.44 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.41 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.77 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.47 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 540.60 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 1.24 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 5.70 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 253.35 Mn
10 Ultragenyx Pharmaceutical 1.48 Bn -321.29 Mn 180.00 Mn 98.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 98.60 Mn
Mar 31, 2026 98.30 Mn
Dec 31, 2025 96.60 Mn
Sep 30, 2025 96.44 Mn
Jun 30, 2025 96.35 Mn
Mar 31, 2025 93.90 Mn
Dec 31, 2024 92.48 Mn
Sep 30, 2024 92.30 Mn
Jun 30, 2024 92.14 Mn
Mar 31, 2024 83.09 Mn
Dec 31, 2023 82.32 Mn
Sep 30, 2023 72.17 Mn
Jun 30, 2023 71.47 Mn
Mar 31, 2023 70.66 Mn
Dec 31, 2022 70.20 Mn
Sep 30, 2022 70.08 Mn
Jun 30, 2022 70.01 Mn
Mar 31, 2022 69.80 Mn
Dec 31, 2021 69.34 Mn
Sep 30, 2021 67.96 Mn
API Access

Ultragenyx Pharmaceutical Shares Outstanding (Entity) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=RARE&period=max&api_key=YOUR_API_KEY